Hydrolytic Lysosomal Glycogen-specific Enzyme class drugs

2 results

Lumizyme (alglucosidase alfa)

(ALGLUCOSIDASE ALFA)
Genzyme Corporation
Usage: LUMIZYME® is indicated for the treatment of Pompe disease, which is caused by acid α-glucosidase (GAA) deficiency.

Nexviazyme (avalglucosidase alfa)

(avalglucosidase alfa)
Genzyme Corporation
Usage: NEXVIAZYME is indicated for treating late-onset Pompe disease in patients aged 1 year and older, specifically for those with lysosomal acid alpha-glucosidase (GAA) deficiency.